Conrad Tenenbaum

Conrad is a Director at Prescient. He holds a PhD in molecular biology from Princeton University. Conrad has seven years of experience in the life science consulting industry, leading a range of commercial strategy engagements covering primary market research, new product planning, brand planning, wargaming, forecasting, HEOR, and value access and pricing. He has particularly deep expertise in primary market research, having worked across HCP, patient, and payer stakeholder types, utilizing both qualitative and quantitative methodologies, and working in various therapeutic areas including CNS, oncology, cardio-metabolic diseases and rare diseases. At Prescient, Conrad will be leading the execution of commercial strategy engagements in the US.